Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort Study

Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort Study

José Javier Morales-Núñez,1 Mariel García-Chagollán,1 José Francisco Muñoz-Valle,1 Saúl Alberto Díaz-Pérez,1 Paola Carolina Torres-Hernández,2 Saraí Citlalic Rodríguez-Reyes,3 Guillermo Santoscoy-Ascencio,4 José Julio Sierra García de Quevedo,4 Jorge Hernández-Bello1 1Institute of Research in Biomed...

Full description

Bibliographic Details
Main Authors: Morales-Núñez JJ, García-Chagollán M, Muñoz-Valle JF, Díaz-Pérez SA, Torres-Hernández PC, Rodríguez-Reyes SC, Santoscoy-Ascencio G, Sierra García de Quevedo JJ, Hernández-Bello J
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:Journal of Inflammation Research
Subjects:
b cell
bnt162b2
sars-cov-2
immunophenotype
vaccine
Online Access:https://www.dovepress.com/differences-in-b-cell-immunophenotypes-and-neutralizing-antibodies-aga-peer-reviewed-fulltext-article-JIR

Internet

https://www.dovepress.com/differences-in-b-cell-immunophenotypes-and-neutralizing-antibodies-aga-peer-reviewed-fulltext-article-JIR

Similar Items